Precision Biosciences DTIL
NASDAQ DTIL
$6.78 +0.07 (+1.04%)
At close: Oct 22, 2026 · 4:00 PM EDT

Precision Biosciences (DTIL) Share-based Compensation (IS) (2025 - 2026)

Updated

Precision Biosciences (DTIL) recorded Share-based Compensation (IS) of $1.84 million in fiscal Q2 2026 (quarter ended Jun 30, 2026), down 37.2% from $2.94 million a year earlier.

Analysis

Precision Biosciences (DTIL) Share-based Compensation (IS) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Precision Biosciences 174.27 Mn -174.91 Mn - 1.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.84 Mn
Jun 30, 2025 2.94 Mn
API Access

Precision Biosciences Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=DTIL&period=max&api_key=YOUR_API_KEY